Enhanced Healthcare Partners has sold MedTest Holdings to HORIBA
Headquartered in Canton, Michigan, MedTest Holdings is a leading provider of clinical testing solutions and open channel reagents for the chemistry, drugs of abuse and toxicology testing markets. MedTest offers a unique combination of screening instruments, reagent manufacturing, service capabilities and liquid chromatography / mass spectrometry toxicology confirmation products under the MedTest Dx, Pointe Scientific, Clinitox Diagnostix and Medical Laboratory Solutions brands. For more information, please visit www.medtestdx.com.
MedTest will strengthen HORIBA Medical’s laboratory chemistry offering while adding complementary research and development and manufacturing expertise within the in vitro diagnostics market.
Lincoln acted as the exclusive financial advisor for MedTest, working closely with its shareholders and management throughout the sale process. This included providing advisory expertise and managing the transaction’s preparatory, marketing, negotiation and due diligence phases. Terms of the transaction were not disclosed.
Meet our Senior Team
View More Transactions in Healthcare
Lincoln International advised Apposite Capital and worked closely with the MC Care team throughout the transaction
Lincoln International advised Thomas H. Lee Partners on the sale of Healthcare Staffing Services to Cornell Capital
Lincoln International is pleased to announce that Homedical Atenção Domiciliar received a strategic investment from Crescera Capital, a leading Brazilian private equity fund
Lincoln International served as the exclusive financial advisor and debt arranger to OrthoFi on its acquisition of OrthoBanc
Lincoln International is pleased to have advised AnGes, Inc. on its acquisition of EmendoBio, Inc., a leader in next-generation novel nuclease discovery and gene editing technologies, at a valuation of $250 million
Lincoln International is pleased to announce that Strive Medical has been acquired by NMS Capital